{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:27:53Z","timestamp":1794436073501,"version":"4.9.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omtn.2026.102887","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T08:53:17Z","timestamp":1772700797000},"page":"102887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["TIPE2 gene knockdown in mice attenuates experimental colitis by diminishing inflammatory cell infiltration"],"prefix":"10.1016","volume":"37","author":[{"given":"Yexiao","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhai H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8930-5262","authenticated-orcid":false,"given":"Guizhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102887_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70160","article-title":"Global and Chinese Burden of Inflammatory Bowel Disease From 1990 to 2021: A Systematic Analysis and Prediction of Disease Burden","volume":"9","author":"Luo","year":"2025","journal-title":"JGH Open"},{"key":"10.1016\/j.omtn.2026.102887_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000543921","article-title":"Colorectal Cancer: Epidemiology, Risk Factors, and Public Health Strategies","volume":"106","author":"Matsuda","year":"2025","journal-title":"Digestion"},{"key":"10.1016\/j.omtn.2026.102887_bib3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41573-024-00953-0","article-title":"Navigating the complexities of drug development for inflammatory bowel disease","volume":"23","author":"Honap","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.102887_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cell.2008.03.026","article-title":"TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis","volume":"133","author":"Sun","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.102887_bib5","doi-asserted-by":"crossref","first-page":"15413","DOI":"10.1073\/pnas.1204525109","article-title":"TIPE2 protein serves as a negative regulator of phagocytosis and oxidative burst during infection","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102887_bib6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni.3866","article-title":"Direction of leukocyte polarization and migration by the phosphoinositide-transfer protein TIPE2","volume":"18","author":"Fayngerts","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2026.102887_bib7","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/ng.3947","article-title":"A functional genomics predictive network model identifies regulators of inflammatory bowel disease","volume":"49","author":"Peters","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2026.102887_bib8","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4049\/jimmunol.1400415","article-title":"Critical roles of TIPE2 protein in murine experimental colitis","volume":"193","author":"Lou","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2026.102887_bib10","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.4049\/jimmunol.1103477","article-title":"TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase-Rac pathway","volume":"189","author":"Sun","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2026.102887_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","article-title":"Mechanisms of Disease: Inflammatory Bowel Diseases","volume":"94","author":"Ramos","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.omtn.2026.102887_bib12","first-page":"1","article-title":"The landscape of new therapeutic opportunities for IBD","volume":"101","author":"Hurtado-Lorenzo","year":"2024","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.omtn.2026.102887_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ibd\/izac246","article-title":"The Clinical Response of Upadacitinib and Risankizumab Is Associated With Reduced Inflammatory Bowel Disease Anti-TNF-\u03b1 Inadequate Response Mechanisms","volume":"29","author":"Wang","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.omtn.2026.102887_bib14","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2147\/JIR.S353038","article-title":"Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics","volume":"15","author":"Lu","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.omtn.2026.102887_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/cpt.6","article-title":"Targeting leukocyte trafficking for the treatment of inflammatory bowel disease","volume":"97","author":"Arseneau","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.omtn.2026.102887_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1586\/17474124.1.1.29","article-title":"Natalizumab: pharmacology, clinical efficacy and safety in the treatment of patients with Crohn's disease","volume":"1","author":"Ko","year":"2007","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2026.102887_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41575-021-00574-7","article-title":"Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease","volume":"19","author":"Verstockt","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2026.102887_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.imlet.2023.02.005","article-title":"TIPE-2 ameliorates inflammatory bowel disease in mice via inhibiting STAT3 and NF-kB activation","volume":"255","author":"Zhou","year":"2023","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.omtn.2026.102887_bib19","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1097\/MIB.0000000000000235","article-title":"Transcriptional analysis of left-sided colitis, pancolitis, and ulcerative colitis-associated dysplasia","volume":"20","author":"Bjerrum","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.omtn.2026.102887_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/MPG.0000000000001898","article-title":"Molecular Comparison of Adult and Pediatric Ulcerative Colitis Indicates Broad Similarity of Molecular Pathways in Disease Tissue","volume":"67","author":"Li","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.omtn.2026.102887_bib21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","article-title":"Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis","volume":"178","author":"Smillie","year":"2019","journal-title":"Cell"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:35:44Z","timestamp":1794432944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2162253126000582"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102887","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TIPE2 gene knockdown in mice attenuates experimental colitis by diminishing inflammatory cell infiltration","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102887"}}